Digestion Or Removing Interfering Materials Patents (Class 436/175)
-
Patent number: 7112453Abstract: This invention provides methods of retentate chromatography for resolving analytes in a sample. The methods involve adsorbing the analytes to a substrate under a plurality of different selectivity conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.Type: GrantFiled: August 5, 2002Date of Patent: September 26, 2006Assignee: Ciphergen Biosystems, Inc.Inventors: T. William Hutchens, Tai-Tung Yip
-
Patent number: 7109039Abstract: A chemical for dissolving a sample taken from the semiconductor device fabrication equipment for analyzing the contaminants attached thereon, and a method of analyzing the contaminants thereby. The chemical composition is made of equal ports of sulfuric acid, hydrogen fluoride, and nitric acid. The method includes a) immersing a sample taken from semiconductor device fabrication equipment in the chemical composition; b) dissolving the sample in the chemical composition; c) cooling the dissolved sample; d) diluting the dissolved sample with deionized water and e) analyzing the diluted sample using either Atomic Absorption Spectrometer or by Atomic Emission Spectroscopy.Type: GrantFiled: December 4, 1998Date of Patent: September 19, 2006Assignee: Samsung Electronics Co., Ltd.Inventor: Yong-woo Hur
-
Patent number: 7045296Abstract: Methods using gel electrophoresis and mass spectrometry for the rapid, quantitative analysis of proteins or protein function in mixtures of proteins derived from two or more samples in one unit operation are disclosed.Type: GrantFiled: May 8, 2001Date of Patent: May 16, 2006Assignees: Applera Corporation, Institute for Systems BiologyInventors: Kenneth C. Parker, Timothy K. Nadler, George J. Vella, Yulin Huang, Rudolf H. Aebersold, Marcus B. Smolka
-
Patent number: 7041510Abstract: A method and apparatus for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled electrokinetic assembly of particles near surfaces relies on the combination of three functional elements: the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.Type: GrantFiled: January 24, 2001Date of Patent: May 9, 2006Assignee: BioArray Solutions Ltd.Inventors: Michael Seul, Chiu Wo Chau
-
Patent number: 7026110Abstract: The invention concerns a reagent for determination of leucocytes and measurement of haemoglobin in a sample of blood. This reagent comprises a buffer system that is suited to adjust selectively the pH of the reagent to an acidic value, at least one detergent of cationic type, a nitrogenous compound and, optionally, at least one inorganic salt. This reagent can be used in haematological analyses in human medicine and also permits the identification of a leucocytic subpopulation, in particular the basophil polymorphonuclear leucocytes.Type: GrantFiled: March 16, 2000Date of Patent: April 11, 2006Assignee: Horiba ABXInventors: Sylvie Veriac, Henri Champseix
-
Patent number: 7026132Abstract: The present invention relates to a method for monitoring the effect of in vivo administration of Cathepsin S inhibitors by measuring accumulation of an intermediate degradation product of invariant chain (Ii), in particular the p10 Ii fragment, in blood of dosed subjects.Type: GrantFiled: August 24, 2001Date of Patent: April 11, 2006Assignee: Ortho-McNeil Pharmaceutical, Inc.Inventors: Robin Thurmond, Siquan Sun, Lars Karlsson
-
Patent number: 7008792Abstract: Methods are provided for measurement of nucleated red blood cells. The methods include exposing a blood cell sample to a reagent system to lyse mature red blood cells, subsequently analyzing nucleated red blood cells in a flow cell by axial light loss, low angle light scatter and DC impedance measurements, or two selected measurements thereof; and then differentiating nucleated red blood cells from other cell types by using measured signals and/or functions thereof.Type: GrantFiled: February 1, 2005Date of Patent: March 7, 2006Assignee: Beckman Coulter, Inc.Inventors: Lidice L. Lopez, Carlos A. Perez, Mark A. Wells, Diana B. Careaga, Ziling Huo, Cheng Qian
-
Patent number: 6995018Abstract: The invention provides methods and compositions for exploiting the discovery that members of the small integrin-binding ligand, n-linked glycoproteins family termed SIBLINGS bind to complement Factor H, and moreover that SIBLINGS proteins, such as BSP, exist in relatively acidic forms. The methods provided can be used to detect SIBLINGS proteins in samples from subjects that are suspected of having tumors or abnormal bone turnover. The invention also provides methods of using SIBLINGS proteins to protect cells from complement mediated lysis. Finally, the discovery allows for the creation of specific binding agents that facilitate the detection of SIBLINGS proteins when they are associated with Factor H.Type: GrantFiled: April 7, 2000Date of Patent: February 7, 2006Assignee: The United States of America as represented by the Secretary of the Department of Health and Human ServicesInventors: Larry W. Fisher, Neal S. Fedarko, Marian F. Young
-
Patent number: 6991941Abstract: A method and apparatus for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled electrokinetic assembly of particles near surfaces relies on the combination of three functional elements: the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.Type: GrantFiled: October 17, 2000Date of Patent: January 31, 2006Assignee: BioArray Solutions Ltd.Inventor: Michael Seul
-
Patent number: 6984526Abstract: A method and apparatus for characterizing the type of a blood sample and a variety of blood components are provided wherein a transmission spectrum of the sample is collected over a predetermined wavelength range. For blood typing, this spectrum is then compared with a set of control spectra collected from control blood samples having known blood types, from which the type of the blood sample can be determined. Further methods and apparatus are provided for determining the viability of and for cross matching a platelet unit. Additional method and apparatus permit analysis of the sample for the presence of a contaminant. Particles can also be counted in the sample, even when present in low concentrations, including white blood cell.Type: GrantFiled: May 21, 2001Date of Patent: January 10, 2006Assignee: University of South FloridaInventors: Luis Humberto Garcia-Rubio, Robert Potter, German Leparc, Sharyn Orton, Yvette Mattley, Christina Bacon
-
Patent number: 6962818Abstract: Mass tagging methods are provided that lead to mass spectrometer detection sensitivities and molecular discriminations that are improved over other methods. In particular the methods are useful for discriminating tagged molecules and fragments of molecules from chemical noise in the mass spectrum. These mass tagging methods are useful for oligomer sequencing, determining the relative abundances of molecules from different samples, and identifying individual molecules or chemical processing steps in combinatorial chemical libraries. The methods provided are useful for the simultaneous analysis of multiple molecules and reaction mixtures by mass spectrometric methods.Type: GrantFiled: October 19, 2001Date of Patent: November 8, 2005Assignee: Target DiscoveryInventors: Luke V. Schneider, Michael P. Hall, Robert Petesch
-
Patent number: 6960477Abstract: Disclosed are a closed heat-decomposing appliance comprising a heating section with one side closed and other side having common ground portion, screw portion or O-ring-mounted portion and a closed introducing section that allows to connect to this heating section and common ground portion, screw portion or O-ring via O-ring-mounted portion and has cock or valve as a mechanism for closing and introducing the absorbing liquid to absorb the testing components from outside after heat-decomposition, or has packing or septum to introduce the absorbing liquid with needle pipe as well, and a pretreatment method of sample using this appliance.Type: GrantFiled: February 1, 2001Date of Patent: November 1, 2005Assignee: Tosoh CorporationInventors: Noriyuki Tanimoto, Yoshimitsu Tada, Hideo Morinaka, Tadashi Okada
-
Patent number: 6958245Abstract: A method and apparatus for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled elektrokinetic assembly of particles near surfaces relies on the combination of three functional elements, the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.Type: GrantFiled: November 28, 2001Date of Patent: October 25, 2005Assignee: Bioarray Solutions Ltd.Inventors: Michael Seul, Alice X. Li
-
Patent number: 6949344Abstract: A method the direct analysis of an analyte in keratinized structures, e.g., hair and fingernails, which comprises preparing a mixture containing a low redox potential activator compound such as dithiothreitol or dithioerythritol, an enzyme suitable for the digestion of the keratin structure, a sample of the keratin structure and a biological detergent that aids the digestion of the keratinized structure at a relatively low pH, e.g., between about 6.2 and 8; permitting the enzyme to at least substantially digest the sample of keratin structure, and subjecting the digest solution to analysis, preferably by radioimmunoassay, to determine the identity and amount of analyte in the keratin structure sample. To accelerate the method, cupric sulfate may be added to the mixture after degradation of the keratin sample. The enzyme may be a peptidase, endopeptidase or proteinase, with papain, chymopapain, and proteinase K being preferred for use in the invention.Type: GrantFiled: July 30, 1991Date of Patent: September 27, 2005Assignee: Psychemical CorporationInventor: Werner Andreas Baumgartner
-
Patent number: 6942835Abstract: The invention provides a test kit, having a tube (17) and a reactant (30) which is held between two holding devices (8, 9). Each holding device has a filter (10), with an elastically deformable part (13) transverse to a disc (11), and a spring (15) which presses the elastically deformable part (13) against the walls of the tube (17).Type: GrantFiled: January 8, 2002Date of Patent: September 13, 2005Assignee: ContralcoInventors: Philippe Monblanc, Bruno Lacan
-
Patent number: 6939715Abstract: A method for separating and purifying the active hematinic species present in iron-saccharidic complexes including sodium ferric gluconate complex in sucrose, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function, based on separation of the iron-saccharidic complex from one or more excipients and, preferably, lyophilization. Separation of the iron-saccharidic complex permits its analytical quantification; further concentration or purification as a new and useful product; preparation of redesigned formulations for new and useful pharmaceuticals; and/or lyophilization.Type: GrantFiled: June 1, 2004Date of Patent: September 6, 2005Assignee: Chromaceutical Advanced Technologies, Inc.Inventors: Robert A. Beck, Robert A. Mateer, Jr.
-
Patent number: 6929955Abstract: The present invention relates to an interactive system comprising at least one active surface of plastic from monomers containing at least one structural element derived from a carbon dioxide (A), and at least one substance associated to a linker with at least one structural element (B) capable of establishing a hydrogen bond, and involving an interaction between the structural elements (A) and (B). That interactive system is suitable for presenting and eliminating substances in liquids.Type: GrantFiled: October 14, 1999Date of Patent: August 16, 2005Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., BerlinInventors: Elke Bucha, Götz Nowak
-
Patent number: 6913896Abstract: In as assay, an analyte is specifically associated with a reporter adenylate kinase, ADP is added and then formation of ATP is monitored. Prior to addition of ADP, adenylate kinase other than reporter adenylate kinase is removed. Assay apparatus comprises a solid phase on which is immobilised the analyte or an antibody specific for the analyte, a reporter composition comprising a thermostable adenylate kinase coupled to an antibody specific for the analyte, and ADP plus associated reagents for conversion of ADP into ATP by thermostable adenylate kinase.Type: GrantFiled: February 3, 2000Date of Patent: July 5, 2005Assignee: Health Protection AgencyInventors: Neil David Hammond Raven, Matthew Patrick Wictome
-
Patent number: 6911313Abstract: A method for discriminating and counting erythroblasts comprises the steps of: (i) staining leukocytes in a hematologic sample by adding a fluorescent labeled antibody capable of binding specifically with leukocytes to the hematologic sample; (ii) raising the permeability only of cell membranes of erythroblasts in the hematologic sample to a nucleotide fluorescent dye which does not permeate a cell membrane usually, the nucleotide fluorescent dye having a fluorescent spectrum capable of being distinguished from that of a fluorescent labeling compound of the fluorescent labeled antibody in step (i); (iii) staining nuclei of the erythroblasts in the hematologic sample with the nucleotide fluorescent dye; (iv) subjecting the hematologic sample to flowcytometry to detect at least two fluorescent signals from each cell; and (v) discriminating and counting the erythroblasts from difference in intensity between the at least two fluorescent signals.Type: GrantFiled: April 9, 1998Date of Patent: June 28, 2005Assignee: Sysmex CorporationInventors: Berend Houwen, Fu-sheng Wang, Tomohiro Tsuji, Takashi Sakata, Yukio Hamaguchi
-
Patent number: 6905879Abstract: Arginine-containing cysteine-modifying compounds useful for MALDI-MS analysis of proteins are provided. These compounds termed isotope-coded ionization enhancement reagents (ICIER) can provide ionization enhancement in MALDI-MS, relative quantitation, and additional database searching constraints at the same time without any extra sample manipulation. More specifically, ICIER increase the ionization efficiency of cysteine-containing peptides by attachment of a guanidino functional group. ICIER also increase the overall hydrophilicity of these peptides due to the hydrophilic nature of ICIER and thus increase the percentage of recovery of these peptides during sample handling and processing such as in-gel digestion or liquid chromatography.Type: GrantFiled: October 22, 2001Date of Patent: June 14, 2005Assignee: Genetics Institute, Inc.Inventors: Yongchang Qiu, Jack H. Wang, Rodney M. Hewick
-
Patent number: 6902936Abstract: The method of the invention provides novel compounds, termed acid-labile isotope-coded extractants (ALICE), for quantitative mass spectrometric analysis of protein mixtures. The compounds contain a thiol-reactive group that is used to capture cysteine-containing peptides from all peptide mixtures, an acid-labile linker, and a non-biological polymer. One of the two acid-labile linkers is isotopically labeled and therefore enables the direct quantitation of peptides/proteins through mass spectrometric analysis. Because no functional proteins are required to capture peptides, a higher percentage of organic solvent can be used to solubilize the peptides, particularly hydrophobic peptides, through the binding, washing and eluting steps, thus permitting much better recovery of peptides. Moreover, since the peptides are covalently linked to the non-biological polymer (ALICE), more stringent washing is allowed in order to completely remove non-specifically bound species.Type: GrantFiled: October 22, 2001Date of Patent: June 7, 2005Assignee: Genentics Institute, Inc.Inventors: Yongchang Qiu, Jack H. Wang, Rodney M. Hewick
-
Patent number: 6900023Abstract: A method for classifying and counting leukocytes comprises the steps of: (1) adding to a hematological sample the following fluorescence-labeled antibodies labeled with fluorescent dyes which emit fluorescences distinguishable from each other; (a) a first fluorescence-labeled antibody (1st antibody) which bonds specifically to leukocytes, (b) a second fluorescence-labeled antibody (2nd antibody) which bonds to at least one kind of neutrophilic cells, and (c) a third fluorescence-labeled antibody (3rd antibody) which bonds to at least one kind of immature granulocytic cells, in order to stain leukocytic cells in the sample, and removing erythrocytes from the sample; (2) analyzing the resulting sample using a flow cytometer to measure at least one scattered light signal and three separate fluorescence signals; (3) defining a group of granulocytic cells on the basis of intensity of the scattered light and intensity of fluorescence from the 1st antibody; (4) defining neutrophilic cells in the defined group of graType: GrantFiled: September 2, 1999Date of Patent: May 31, 2005Assignee: Sysmex CorporationInventors: Berend Houwen, Fu-sheng Wang, Hiroyuki Fujimoto, Takashi Sakata, Yukio Hamaguchi
-
Patent number: 6890756Abstract: A method of emulating with a cyanide-free lyse solution, the measurement of hemoglobin in whole blood using a cyanide-containing lyse solution. Such an illustrative method includes: a) combining a predetermined amount of the whole blood sample with a predetermined amount of a cyanide-free lyse solution to form a mixture, b) developing the mixture to a molar absorbtivity (?) in the range of about 12.4 to 12.6 mM?1cm?1, and c) measuring a level of light absorbance of the mixture at a wavelength of about 540 nm. In one preferred illustrative embodiment, the cyanide-free lyse solution includes: a quaternary ammonium salt surfactant, an anionic surfactant, a hemoglobin binding agent selected from the group consisting of imidazole or hydroxylamine, and an aqueous medium. In one preferred embodiment, the molar absorbtivity is developed to a value of about 12.5 mM?1cm?1. That is to say to a level that is substantially identical to that of the prior art standard, cyanomethemoglobin.Type: GrantFiled: April 7, 2003Date of Patent: May 10, 2005Assignee: Streck Laboratories, Inc.Inventor: Jiong Wu
-
Patent number: 6887713Abstract: The present invention is directed to a bioactive probe or chip (BC) that allows for the isolation of analytes, such as biomolecules, followed by modification or bioreaction on these said analytes. More specifically, the present invention relates to various methods and apparatuses that include the BC and further include characterization and identification technologies, such as Bioactive Chip Mass Spectrometry (BCMS). Within the context of the present invention, BC provides a method and device for the capture and subsequent modifying, such as digestion or derivatization, of an analyte. Further, real-time information regarding a variety of molecular interactions may be provided by techniques such as interaction analysis (IA). Finally, the variety of molecules are localized and concentrated thereby aiding in the identification and/or quantification of the molecules by techniques such as mass spectroscopy. In one embodiment, a method for performing the modification, or bioreaction, of biomolecules is disclosed.Type: GrantFiled: February 4, 2003Date of Patent: May 3, 2005Assignee: Intrinsic Bioprobes, Inc.Inventors: Randall W. Nelson, Dobrin Nedelkov
-
Patent number: 6881581Abstract: An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design is such that removal of non-HDL lipoproteins from a sample and assay of HDL cholesterol in the sample occur without interruption of the assay. The device also prevents interference by reagents used for the HDL assay with other assays carried out on the same sample.Type: GrantFiled: January 17, 2003Date of Patent: April 19, 2005Assignee: Cholestech CorporationInventors: Ronald M. Jones, Thomas E. Worthy, Anthony J. Nugent
-
Patent number: 6878339Abstract: The present invention provides a NOx-concentration measuring apparatus D for quantitatively analyzing the concentration of NOx contained in a sample gas. The measuring apparatus D comprises a sampling probe for obtaining the sample gas, a drain separator 2 for condensing moisture contained in the sample gas as a condensed water and separating the condensed water from the sample gas, an NO2 converter 3 for converting NO2 contained in the sample gas into NO, a secondary cooling device 7 for additionally cooling the sample gas, and an NO analyzer 1, arranged in this order with respect to a sample-gas line of the NOx-concentration measuring apparatus. The drain separator is a high-flow-velocity cooling type drain separator. Further, the sample-gas line between the sampling probe and the drain separator is heated and/or thermally insulated over the entire length thereof. The measuring apparatus can provide a high-precision measurement while suppressing NO2 loss.Type: GrantFiled: February 19, 2003Date of Patent: April 12, 2005Assignee: Horiba, Ltd.Inventors: Shigeyuki Akiyama, Satoshi Inoue, Masahiko Fujiwara
-
Patent number: 6867002Abstract: A sample solution treating instrument is provided for facilitating rapid and simplified adjustment of the condition of a sample solution proper for analysis with a biosensor before supplying the solution to the biosensor. The sample solution treating instrument includes, for example, a catalyst or an adsorbent which can remove any interfering substance in order to adjust the sample solution for measurement with a biosensor.Type: GrantFiled: October 20, 1999Date of Patent: March 15, 2005Assignee: Matsushita Electric Industrial Co., Ltd.Inventors: Mariko Miyashita, Toshihiko Yoshioka, Shiro Nankai
-
Patent number: 6861266Abstract: Methods are disclosed for calculating the concentration of a predetermined substance in the blood of a mammal including passing the blood over one side of a semipermeable membrane in a dialyser and passing a dialysis fluid on the other side of the semipermeable membrane in the dialyser to provide a dialysate, measuring the concentration of the predetermined substance in the dialysate, introducing a disturbance in the dialyser, calculating the effective dialysance of the dialyser based on the disturbance, and calculating the concentration of the predetermined substance in the blood based upon the effective dialysance. Apparatus is also disclosed for calculating the concentration of the predetermined substance in the blood.Type: GrantFiled: December 2, 1998Date of Patent: March 1, 2005Assignee: Gambro Lundia ABInventor: Jan Sternby
-
Patent number: 6855561Abstract: A test device and method for determining the presence or absence of an analyte in a fluid sample, the test device including a support bearing a mark thereon, and a matrix defining an axial flow path. In operation, an observation area in the test device becomes transparent, thereby allowing the user to view a mark that is present on a support that is disposed beneath the observation area. Typically, the mark on the underlying support is configured as a minus (?) sign. In the absence of analyte in the sample, the test device presents a negative result as a minus (?) signal. In the presence of analyte in the sample, however, the mark operates in concert with a perpendicular test line on the observation area to present a positive result as a plus (+) signal that is visible to the user.Type: GrantFiled: September 10, 2001Date of Patent: February 15, 2005Assignee: Quidel CorporationInventors: Jeremy Jerome, Mark Daquipa, Bruce Jacono, Hans Boehringer
-
Patent number: 6855559Abstract: The present invention provides reagents for use in an automated environment for removing or etching embedding media by exposing a biological sample to be stained in histochemical or cytochemical procedures without the dependence on organic solvents. The reagents comprise components optimized to facilitate removal or etching of the embedding media from the biological sample. The present invention also provides reagents for use in an automated environment for cell conditioning biological samples wherein the cells are predisposed for access by reagent molecules for histochemical and cytochemical staining procedures. The reagents comprise components optimized to facilitate molecular access to cells and cell constituents within the biological sample.Type: GrantFiled: November 22, 2000Date of Patent: February 15, 2005Assignee: Ventana Medical Systems, Inc.Inventors: Kimberly Christensen, Ethel R. Macrea, Noemi Sebastiao
-
Patent number: 6852544Abstract: Analytical reagents and mass spectrometry-based methods using these reagents for the rapid, and quantitative analysis of proteins or protein function in mixtures of proteins. The methods employ affinity labeled protein reactive reagents having three portions: an affinity label (A) covalently linked to a protein reactive group (PRG) through a linker group (L). The linker may be differentially isotopically labeled, e.g., by substitution of one or more atoms in the linker with a stable isotope thereof. These reagents allow for the selective isolation of peptide fragments or the products of reaction with a given protein (e.g., products of enzymatic reaction) from complex mixtures. The isolated peptide fragments or reaction products are characteristic of the presence of a protein or the presence of a protein function in those mixtures. Isolated peptides or reaction products are characterized by mass spectrometric (MS) techniques.Type: GrantFiled: April 20, 2001Date of Patent: February 8, 2005Assignee: University of WashingtonInventors: Rudolf Hans Aebersold, Michael H. Gelb, Steven P. Gygi, C. Ronald Scott, Frantisek Turecek, Scott A. Gerber, Beate Rist
-
Patent number: 6852284Abstract: The present invention provides an apparatus and method for storing a particle-containing liquid. The storage apparatus comprises a microfluidic convoluted flow channel having a plurality of article capture regions. The storage channel is preferably an isotropic spatially periodic channel. Sedimented particles can be resuspended following storage. This invention further provides a microfluidic analysis cartridge having a convoluted storage channel therein. The sample analysis can use optical, electrical, pressure sensitive, or flow sensitive detection. A plurality of analysis channels can be included in a single cartridge. The analysis channels can be joined to reagent inlets for diluents, indicators or lysing agents. A mixing channel can be positioned between the reagent inlet and the analysis region to allow mixing and reaction of the reagent. The cartridge can include additional valves and pumps for flow management.Type: GrantFiled: October 13, 2000Date of Patent: February 8, 2005Assignee: University of WashingtonInventors: Mark R. Holl, Floyd Edwards, Robert J. Morff, Gerald L. Klein
-
Patent number: 6830933Abstract: Amlodipine aspartate and amlodipine maleamide are used as reference standards or markers in determining the purity of amlodipine maleate substances and products.Type: GrantFiled: August 27, 2001Date of Patent: December 14, 2004Assignee: Synthon BVInventors: Jacobus M Lemmens, Theodorus H. A. Peters, Peter F. A. Bakker, Frantisek Picha
-
Patent number: 6828157Abstract: A method of single parameter and multiparameter characterizing of cells, particularly immunophenotyping of cells, is provided. The method preferably uses antibody coated microspheres which are adapted to bind to specific types of cells. One or more sets of coated microspheres are added simultaneously or sequentially to a suspension of cells and bind the cells they are adapted to bind. Cells may bind to one or more microspheres. The suspension is then filtered to trap bead-cell complexes. The complexes are preferably stained and then examined to characterize the cells, preferably the cells bound to the microspheres. A kit and apparatus for performing the method are also provided.Type: GrantFiled: May 3, 2000Date of Patent: December 7, 2004Inventor: Dan A. Pankowsky
-
Publication number: 20040241046Abstract: Apparatus for digesting a liquid sample has sealed housing (18) containing a source (20) of ultra violet radiation, such as a medium pressure mercury discharge lamp, for irradiating a liquid sample being conveyed through a conduit (24) also in the housing (18). The source (20) emits ultra violet radiation, in a first frequency band, for generating ozone in the sample and in a second, lower frequency band for breaking chemical bands, and creating free radicals in the sample. The apparatus may include an analyser, such as an ion chromatograph (12) connected to the sample digester.Type: ApplicationFiled: February 10, 2004Publication date: December 2, 2004Inventors: John Francis Bates, Christopher George Perry
-
Patent number: 6825045Abstract: A system and method for desorption and ionization of analytes in an ablation medium. In one embodiment, the method includes the steps of preparing a sample having analytes in a medium including at least one component, freezing the sample at a sufficiently low temperature so that at least part of the sample has a phase transition, and irradiating the frozen sample with short-pulse radiation to cause medium ablation and desorption and ionization of the analytes. The method further includes the steps of selecting a resonant vibrational mode of at least one component of the medium and selecting an energy source tuned to emit radiation substantially at the wavelength of the selected resonant vibrational mode. The medium is an electrophoresis medium having polyacrylamide. In one embodiment, the energy source is a laser, where the laser can be a free electron laser tunable to generate short-pulse radiation. Alternatively, the laser can be a solid state laser tunable to generate short-pulse radiation.Type: GrantFiled: August 16, 2001Date of Patent: November 30, 2004Assignee: Vanderbilt UniversityInventors: Richard F. Haglund, Jr., David R. Ermer, Michelle Lee Baltz-Knorr
-
Patent number: 6818112Abstract: The present method provides methods and apparatus for separating proteins using a series of electrophoretic methods that utilize controlled fractionation and labeling techniques to resolve mixtures of proteins. The samples for each electrophoretic method other than the initial method, contain only a subset of proteins resolved in the preceding method. The methods can be used in a variety of different applications including, creating proteomic databases, comparative expression studies, diagnostics, structure activity relationships and metabolic engineering investigations.Type: GrantFiled: January 13, 2003Date of Patent: November 16, 2004Assignee: Target Discovery, Inc.Inventors: Luke V. Schneider, Michael P. Hall, Robert Petesch
-
Patent number: 6815216Abstract: The invention relates to a method for solid-phase microextraction and analysis of substances in a carrier fluid, in which a collector is brought into contact with the stirred fluid containing the substances for a sufficient time and is then subjected to a solid-phase extraction directed at at least one substance adhering to the collector, and desorbed substances are transported for analysis by means of a carrier gas, in which the carrier fluid containing the substances is stirred in a receptacle of a magnetic stirrer by means of a coated magnetic stirring element as the collector, and/or the carrier fluid is made to move intimately relative to the collector by means of ultrasound, and then the stirring element is placed in a solid-phase extraction device.Type: GrantFiled: September 27, 2001Date of Patent: November 9, 2004Assignee: Gerstel Systemtechnik GmbH & Co. KGInventors: Patrick Sandra, Erik Baltussen, Frank David
-
Patent number: 6812032Abstract: An apparatus is provided for hematology testing, which has a sensing unit defining a counting orifice for the flow of a blood sample through the counting orifice to analyze the blood sample, and a pump unit having three syringes. A first syringe is coupled in fluid communication with the sensing unit on the inlet side of the counting orifice for injecting a stream of blood sample through the counting orifice. A second syringe is coupled in fluid communication with the sensing chamber on the inlet side of the counting orifice for simultaneously injecting a sheath of fluid surrounding the sample stream on the inlet side of the counting orifice. And a third syringe is coupled to the sensing chamber on the outlet side of the counting orifice for aspirating a sheath of fluid from the sensing chamber surrounding the sample stream on the outlet side of the counting orifice.Type: GrantFiled: March 16, 1998Date of Patent: November 2, 2004Assignee: CDC Technologies, Inc.Inventors: Edward Lawrence Carver, Jr., David Charles DeCava
-
Patent number: 6808931Abstract: A method for the determination of hexavalent chromium (CrVI) in environmental and industrial hygiene samples is provided. Based on the chemical properties of chromium species in aqueous solutions, a simple, fast, sensitive, and economical field method has been developed and evaluated for the determination of hexavalent chromium (CrVI). Using ultrasonic extraction in combination with a strong anion exchange solid phase extraction (SAE-SPE) technique, the filtration, preconcentration, and isolation of CrVI in the presence of other chromium species and interferents was achieved.Type: GrantFiled: October 10, 2000Date of Patent: October 26, 2004Assignee: The United States of America as represented by the Secretary of Health and Human ServicesInventors: Jin Wang, Kevin Ashley
-
Patent number: 6803237Abstract: A sequential processing reactor vessel and method is disclosed for accelerated extraction and fractionation of chemical analytes from complex solid sample materials. The device and method provide for sequential extraction of elemental constituents from solid materials by sequentially contacting target samples within a single reaction vessel using a series of different reagents at temperatures as high as 150° C. and pressures up to 150 psi to accelerate reactions. The aggressive chemical treatments provided by the disclosed device and method enable the complete digestion of solid samples in liquid analyte samples that can be directly analyzed by conventional spectrometry or other suitable methods. The disclosed device and method provide for efficient sample processing and accelerated reactions to significantly reduce processing times and costs for elemental analysis of solids while improving accuracy, precision and reliability of results compared to conventional devices and methods.Type: GrantFiled: January 25, 2001Date of Patent: October 12, 2004Assignee: Woods Hole Oceanographic InstitutionInventors: Steven J. Manganini, Kenneth W. Doherty, Terence R. Hammer, Bruce A. Lancaster
-
Patent number: 6797482Abstract: The present invention provides methods whereby the positions of peptide amide groups that are labeled with a heavy hydrogen in a polypeptide or protein can be localized at high resolution. The methods are useful for determining which peptide amide groups in a polypeptide or protein are accessible to solvent, mapping the binding site and/or binding surface of a binding protein, and/or studying allosteric or other conformational changes in a polypeptide or protein which alter the rates at which certain peptide amide hydrogens exchange with solvent.Type: GrantFiled: September 10, 2001Date of Patent: September 28, 2004Assignee: ExSAR CorporationInventor: Virgil L. Woods, Jr.
-
Patent number: 6790668Abstract: The present invention is a method for drug level detection by using a simplified and effective deproteinizing step from body fluids, such as plasma, blood, urine, saliva, tear fluid, followed by drug extraction and measurement using an accurate technique, such as a colorimetric assay or a High-Performance Liquid Chromatography method. In a particular embodiment, the invention is directed to a method to quantify rifampicin in order to monitor its levels in body fluids and also to a Kit for rifampicin concentration measurement.Type: GrantFiled: September 7, 2000Date of Patent: September 14, 2004Assignee: Fundacao Oswaldo Cruz - FiocruzInventors: Milton F. Ferreira, Vera L. Luiza, Eduardo W. Barroso, André L. Gemal
-
Patent number: 6783734Abstract: A tissue sample is conventionally visualized in a microscope. A selectively activated convex surface is provided, preferably at the distal end of a rod. This selectively activated convex surface when activated, typically with a laser through an optic light path in the microscope, provides the activated region with adhesive properties. At least one portion of the tissue sample which is to be extracted is identified. This identified portion is contacted with a portion of the selectively activated convex surface on the end of the rod. When the convex surface is activated, typically by exposure to laser light in the footprint of the desired sample, an adhesive transfer surface on the selectively activated convex surface is provided which adheres to the desired cells in the footprint of the desired sample. Thereafter, the adhesive transfer surface is separated from the remainder of the tissue sample while maintaining adhesion with the desired cells. Thus the desired portion of the tissue sample is extracted.Type: GrantFiled: September 1, 1999Date of Patent: August 31, 2004Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: Seth R. Goldstein, Robert F. Bonner, Paul D. Smith, John Peterson, Thomas Pohida
-
Publication number: 20040092031Abstract: A metal chelating composition having the formula: 1Type: ApplicationFiled: September 22, 2003Publication date: May 13, 2004Applicant: Sigma - Aldrich Co.Inventors: William K. Kappel, Venkatappa Viswanatha, Handong Li, Richard J. Mehigh, John G. Dapron
-
Patent number: 6709868Abstract: A method for quantitatively measuring white blood cell count involves capture of white blood cells from a fluid sample by a retainer, removal of the red blood cells and other interfering substances by a wash solution, and reading the result of a color reaction in which an ester which is present on the white blood cells cleaves a chromogenic substrate which produces a water insoluble dye. The apparatus for use in the present method includes a retainer for white blood cells that has a dye substrate immobilized therein and an absorption layer that wicks and takes up all excess washing solution flowing past the sample.Type: GrantFiled: May 20, 2002Date of Patent: March 23, 2004Assignee: Portascience Inc.Inventors: Wai Tak Law, Yuri Nikolyukin, Inna Nikolyukin
-
Patent number: 6706486Abstract: The present invention relates to a method for the quantitative release of natural or recombinant proteins, polypeptides (thermostable immunoligands) able to bind to the Fc-part of immunoglobulins (antibodies, in particular of the IgG class and primarily becoming bound outside the paratope) from complexes in various sample matrixes in order to make these released natural or recombinant proteins, polypeptides or peptides quantitatively available in immunochemical assays and to keep them quantitatively available. The method is characterized by mixing the sample with reagent compound that is able to bind non-specifically to immunoglobulins, and thereafter subjecting the sample to a heat treatment step followed by a cooling step.Type: GrantFiled: February 15, 2001Date of Patent: March 16, 2004Assignee: Amersham Biosciences ABInventor: Franz Steindl
-
Publication number: 20040043500Abstract: An apparatus and system for wafer-scale microwave digestion of layers or structures from a large-scale semiconductor substrate include a digestion vessel with a chamber which is configured to receive a whole large-scale semiconductor substrate, such as a silicon wafer. The digestion vessel may be configured to be placed within a containment apparatus, which structurally supports the digestion vessel. A digestion method includes placing at least one large-scale semiconductor substrate within the digestion vessel with a polar solvent, placing the digestion vessel within the containment apparatus, placing the containment apparatus in a microwave oven or other microwave source, and heating the polar solvent and substrate with microwaves. The heated polar solvent dissolves one or more desired layers or structures and may be subsequently analyzed to evaluate the amounts of one or more materials of such layers or structures.Type: ApplicationFiled: August 27, 2002Publication date: March 4, 2004Inventors: J Eric Rumps, Ronald F. Baldner
-
Patent number: 6699720Abstract: The present invention relates to an interference-eliminating membrane for use in detecting uric acid in a sample, comprising a compound for inhibiting or shading uric acid interfering substances, or derivatives thereof, and a carrier having an absorption property and permeability for the sample; and a process for preparing the interference-eliminating membrane. The present invention also provides a test strip for use in detecting uric acid in a sample, comprising a reagent reaction layer or optional interference-eliminating membranes and/or support layers; and a kit comprising the test strip of the invention.Type: GrantFiled: May 26, 2000Date of Patent: March 2, 2004Assignee: Development Center for BiotechnologyInventors: Tsai Yun Lee, Yi Chih Lei, Shi-Yuan Sheu, Yu Fen Tsai, Tai-Guang Wu, Hung-Hsiu Ho, Ming-Yen Kuo, Jiuan J. Liu, Tong H. Chang, Hsueh-Fang Chen, Liahng-Yirn Liu
-
Patent number: 6696300Abstract: An improved method for the analysis of arsenic in an aqueous sample, is disclosed. In accordance with the inventive method, arsenic is reduced to arsine gas in an acidic aqueous reaction environment and in the presence of an effective amount of an agent for increasing the rate of arsine gas production. Beneficially, metal cations are used as rate-increasing agents.Type: GrantFiled: November 9, 2001Date of Patent: February 24, 2004Assignee: Industrial Test Systems, Inc.Inventors: Ivars Jaunakais, Lea Marianne Jaunakais, Corlyss Brown Lewis